Global Health Share Price
Sector: Healthcare Facilities
1151.00 +19.10 (1.69%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1136.10
Today’s High
1189.95
52 Week Low
936.05
52 Week High
1323.85
1150.00 +16.60 (1.46%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1133.40
Today’s High
1154.90
52 Week Low
935.50
52 Week High
1324.70
Key Metrics
- Market Cap (In Cr) 30884.3
- Beta -
- Div. Yield (%) 0.04
- P/B 8.99
- TTM P/E 66.87
- Peg Ratio 1.82
- Sector P/E 22.44
- D/E 0
- Open Price 1189.95
- Prev Close 1131.9
Global Health Analysis
Price Analysis
-
1 Week-2.55%
-
3 Months-6.63%
-
6 Month2.32%
-
YTD5.09%
-
1 Year-13.19%
Risk Meter
- 34% Low risk
- 34% Moderate risk
- 34% Balanced Risk
- 34% High risk
- 34% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 4
- 5
- Buy
- 3
- 3
- 3
- 2
- Hold
- 2
- 2
- 2
- 2
- Sell
- 2
- 2
- 2
- 2
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 11
- 11
- 11
- 11
Global Health News
Women, think you are low on vitamins or calcium? Focus on your plate
3 min read . 25 Jun 2025Colgate-Palmolive eyes H2 rebound amid urban stress, rural growth
3 min read . 23 Jun 2025Global Health Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 3692.32
- Selling/ General/ Admin Expenses Total
- 1321.89
- Depreciation/ Amortization
- 193.75
- Other Operating Expenses Total
- 613.7
- Total Operating Expense
- 3058.9
- Operating Income
- 633.42
- Net Income Before Taxes
- 647.26
- Net Income
- 481.44
- Diluted Normalized EPS
- 19.3
- Period
- 2025
- Total Assets
- 4766.23
- Total Liabilities
- 1379.82
- Total Equity
- 3386.41
- Tangible Book Valueper Share Common Eq
- 125.66
- Period
- 2025
- Cashfrom Operating Activities
- 623.76
- Cashfrom Investing Activities
- -720.94
- Cashfrom Financing Activities
- -97.23
- Net Changein Cash
- -194.41
- Period
- 2024
- Total Revenue
- 3275.11
- Selling/ General/ Admin Expenses Total
- 1698.6
- Depreciation/ Amortization
- 172.73
- Other Operating Expenses Total
- 4.9
- Total Operating Expense
- 2635.63
- Operating Income
- 639.48
- Net Income Before Taxes
- 627.1
- Net Income
- 478.19
- Diluted Normalized EPS
- 17.78
- Period
- 2024
- Total Assets
- 4304.08
- Total Liabilities
- 1398.45
- Total Equity
- 2905.63
- Tangible Book Valueper Share Common Eq
- 108.01
- Period
- 2024
- Cashfrom Operating Activities
- 612.08
- Cashfrom Investing Activities
- -440.79
- Cashfrom Financing Activities
- -513.92
- Net Changein Cash
- -342.64
- Period
- 2023
- Total Revenue
- 2694.25
- Selling/ General/ Admin Expenses Total
- 1436.84
- Depreciation/ Amortization
- 149.91
- Other Operating Expenses Total
- 3.49
- Total Operating Expense
- 2215.57
- Operating Income
- 478.68
- Net Income Before Taxes
- 449.29
- Net Income
- 326.08
- Diluted Normalized EPS
- 12.59
- Period
- 2023
- Total Assets
- 4115.96
- Total Liabilities
- 1687.76
- Total Equity
- 2428.21
- Tangible Book Valueper Share Common Eq
- 90.35
- Period
- 2023
- Cashfrom Operating Activities
- 644.52
- Cashfrom Investing Activities
- -342.34
- Cashfrom Financing Activities
- 345.64
- Net Changein Cash
- 647.81
- Period
- 2022
- Total Revenue
- 2166.59
- Selling/ General/ Admin Expenses Total
- 1165.26
- Depreciation/ Amortization
- 129.71
- Other Operating Expenses Total
- 6
- Total Operating Expense
- 1843.95
- Operating Income
- 322.64
- Net Income Before Taxes
- 280.56
- Net Income
- 196.2
- Diluted Normalized EPS
- 7.25
- Period
- 2022
- Total Assets
- 3145.52
- Total Liabilities
- 1529.51
- Total Equity
- 1616.01
- Tangible Book Valueper Share Common Eq
- 60.02
- Period
- 2022
- Cashfrom Operating Activities
- 311.26
- Cashfrom Investing Activities
- -420.89
- Cashfrom Financing Activities
- 159.59
- Net Changein Cash
- 49.97
- Period
- 2021
- Total Revenue
- 1446.74
- Selling/ General/ Admin Expenses Total
- 897.85
- Depreciation/ Amortization
- 123.21
- Other Operating Expenses Total
- 4.76
- Total Operating Expense
- 1375.66
- Operating Income
- 71.08
- Net Income Before Taxes
- 32.46
- Net Income
- 28.81
- Diluted Normalized EPS
- 1.06
- Period
- 2021
- Total Assets
- 2694.11
- Total Liabilities
- 1311.76
- Total Equity
- 1382.34
- Tangible Book Valueper Share Common Eq
- 50.06
- Period
- 2021
- Cashfrom Operating Activities
- 241.77
- Cashfrom Investing Activities
- -239.15
- Cashfrom Financing Activities
- -80.72
- Net Changein Cash
- -78.1
- Period
- 2020
- Total Revenue
- 1500.42
- Selling/ General/ Admin Expenses Total
- 983.52
- Depreciation/ Amortization
- 115.04
- Other Operating Expenses Total
- 2.6
- Total Operating Expense
- 1425.97
- Operating Income
- 74.45
- Net Income Before Taxes
- 63.87
- Net Income
- 36.33
- Diluted Normalized EPS
- 1.36
- Period
- 2020
- Total Assets
- 2666.29
- Total Liabilities
- 1316.75
- Total Equity
- 1349.54
- Tangible Book Valueper Share Common Eq
- 48.79
- Period
- 2020
- Cashfrom Operating Activities
- 175.07
- Cashfrom Investing Activities
- -87.07
- Cashfrom Financing Activities
- -0.88
- Net Changein Cash
- 87.12
- Period
- 2025-03-31
- Total Revenue
- 931.25
- Selling/ General/ Admin Expenses Total
- 335.65
- Depreciation/ Amortization
- 49.25
- Other Operating Expenses Total
- 157.29
- Total Operating Expense
- 805.71
- Operating Income
- 125.54
- Net Income Before Taxes
- 133.44
- Net Income
- 101.4
- Diluted Normalized EPS
- 5.18
- Period
- 2025-03-31
- Total Assets
- 4766.23
- Total Liabilities
- 1379.82
- Total Equity
- 3386.41
- Tangible Book Valueper Share Common Eq
- 125.66
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 623.76
- Cashfrom Investing Activities
- -720.94
- Cashfrom Financing Activities
- -97.23
- Net Changein Cash
- -194.41
- Period
- 2024-12-31
- Total Revenue
- 943.44
- Selling/ General/ Admin Expenses Total
- 329.96
- Depreciation/ Amortization
- 48.45
- Other Operating Expenses Total
- 143.1
- Total Operating Expense
- 754.12
- Operating Income
- 189.32
- Net Income Before Taxes
- 189.07
- Net Income
- 142.91
- Diluted Normalized EPS
- 5.42
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 956.56
- Selling/ General/ Admin Expenses Total
- 336.62
- Depreciation/ Amortization
- 49.43
- Other Operating Expenses Total
- 157.58
- Total Operating Expense
- 777.7
- Operating Income
- 178.86
- Net Income Before Taxes
- 181.1
- Net Income
- 130.84
- Diluted Normalized EPS
- 5.03
- Period
- 2024-09-30
- Total Assets
- 4510.08
- Total Liabilities
- 1368.6
- Total Equity
- 3141.49
- Tangible Book Valueper Share Common Eq
- 116.64
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 299.27
- Cashfrom Investing Activities
- -308.91
- Cashfrom Financing Activities
- -115.2
- Net Changein Cash
- -124.84
- Period
- 2024-06-30
- Total Revenue
- 861.08
- Selling/ General/ Admin Expenses Total
- 319.66
- Depreciation/ Amortization
- 46.62
- Other Operating Expenses Total
- 141.32
- Total Operating Expense
- 721.37
- Operating Income
- 139.7
- Net Income Before Taxes
- 143.65
- Net Income
- 106.29
- Diluted Normalized EPS
- 4.1
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 825.53
- Selling/ General/ Admin Expenses Total
- 308.12
- Depreciation/ Amortization
- 45.45
- Other Operating Expenses Total
- 127.42
- Total Operating Expense
- 674.74
- Operating Income
- 150.79
- Net Income Before Taxes
- 143.09
- Net Income
- 127.38
- Diluted Normalized EPS
- 4.73
- Period
- 2024-03-31
- Total Assets
- 4304.08
- Total Liabilities
- 1398.45
- Total Equity
- 2905.63
- Tangible Book Valueper Share Common Eq
- 108.01
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 612.08
- Cashfrom Investing Activities
- -440.79
- Cashfrom Financing Activities
- -513.92
- Net Changein Cash
- -342.64
- Period
- 2023-12-31
- Total Revenue
- 832.6
- Selling/ General/ Admin Expenses Total
- 302.08
- Depreciation/ Amortization
- 43.98
- Other Operating Expenses Total
- 127.76
- Total Operating Expense
- 664.49
- Operating Income
- 168.11
- Net Income Before Taxes
- 172.36
- Net Income
- 123.64
- Diluted Normalized EPS
- 4.6
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Global Health Technical
Moving Average
SMA
- 5 Day1141.98
- 10 Day1165.73
- 20 Day1184.05
- 50 Day1204.86
- 100 Day1190.96
- 300 Day1135.21
Global Health Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Fortis Healthcare
- 799.65
- 8.75
- 1.11
- 793.35
- 452.75
- 60498.26
- Narayana Hrudayalaya
- 2034.9
- -35.9
- -1.73
- 2145
- 1171.35
- 41622.67
- Global Health
- 1151
- 19.1
- 1.69
- 1323.85
- 936.05
- 30884.3
- Aster Dm Healthcare
- 587.6
- -9
- -1.51
- 609
- 315.5
- 30444.79
- Krishna Instit Of Medical Scienc
- 669.1
- -7.4
- -1.09
- 707.5
- 404.12
- 26773.29
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Fortis Healthcare
- 69.55
- 6.6
- 6.88
- 9.18
- Narayana Hrudayalaya
- 52.51
- 11.53
- 25.11
- 11.8
- Global Health
- 58.41
- 8.94
- 14.18
- 11.38
- Aster Dm Healthcare
- 86.15
- 8.6
- 6.16
- 4.98
- Krishna Instit Of Medical Scienc
- 69.32
- 12.21
- 21.99
- 15.55
Global Health Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 15-May-25
- Audited Results & Final Dividend
- 04-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 17-May-24
- Audited Results
- 08-Feb-24
- Quarterly Results
- 09-Nov-23
- Quarterly Results
- 10-Aug-23
- Quarterly Results
- 27-May-23
- Audited Results
- 13-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 17-Mar-25
- 11-Feb-25
- POM
- 29-Dec-24
- 26-Nov-24
- POM
- 19-Sept-24
- 08-Aug-24
- AGM
- 03-Aug-24
- 02-Jul-24
- COM
- 20-Sept-23
- 10-Aug-23
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 15-May-25
- -
- -
- 0.5


